American BioScience Sues Over Patent

American BioScience Inc., owner of a patent on Bristol-Myers Squibb Co.’s cancer-treatment drug Taxol, has sued the Food and Drug Administration for the second time over its approval of Ivax Corp.’s generic version of the drug. Bristol-Myers, Ivax and Santa Monica-based American BioScience also are fighting in federal courts in New York and Washington and in a Florida state court, with the FDA a defendant in the Washington suit.